Features | Partner Sites | Information | LinkXpress
Sign In
GLOBETECH PUBLISHING
JIB
GLOBETECH PUBLISHING

Nematode Infection Controls Obesity and Modulates Body Weight and Metabolism

By BiotechDaily International staff writers
Posted on 09 May 2013
In an interesting combination of low and high technology approaches to the control and treatment of obesity, a recent study suggested that infection with parasitic nematodes (roundworms) could suppress the chronic inflammation associated with obesity and modulate body weight and metabolism.

Obesity is associated with a chronic low-grade inflammation characterized by increased levels of proinflammatory cytokines that are implicated in metabolic dysfunction. Nematode infection, which elevates host immune Th2-cells and related type two cytokines, has been used in ancient medicine and is currently under clinical investigation for treatment for diseases associated with the relevant cytokines, including inflammatory bowel disease, multiple sclerosis, and allergies

Investigators at the University of Maryland School of Medicine (Baltimore, USA) examined the possibility of using nematode infection to treat obesity. They worked with several strains of mice that were fed normal or high-fat diets.

They reported in the March 18, 2013, online edition of the journal Infection and Immunity that normal size mice infected with the nematode Nippostrongyrus brasiliensis fed a high-fat diet gained 15% percent less weight than control animals that were not infected. Mice that were already obese when infected lost roughly 13% of their body weight within 10 days. Infected animals were found to have decreased fasting blood glucose levels and reduced incidence of fatty liver disease.

"The levels of insulin and leptin also dropped, indicating that the mice restored their sensitivities to both hormones," said senior author Dr. Aiping Zhao, associate professor of radiation oncology at the University of Maryland School of Medicine. "Leptin moderates appetite. As with too much insulin, too high a level of leptin results in insensitivity, thus contributing to obesity and metabolic syndrome."

Related Links:

University of Maryland School of Medicine



comments powered by Disqus

Channels

Drug Discovery

view channel
Image: Synthetic ion transporters can induce apoptosis by facilitating chloride anion transport into cells (Photo courtesy of the University of Texas, Austin).

Experimental Drug Kills Cancer Cells by Interfering with Their Ion Transport Mechanism

An experimental anticancer drug induces cells to enter a molecular pathway leading to apoptosis by skewing their ion transport systems to greatly favor the influx of chloride anions. To promote development... Read more

Therapeutics

view channel
Image: Liver cells regenerated in mice treated with a new drug (right) compared with a control group (center) after partial liver removal. Healthy liver cells are shown at left (Photo courtesy of Marshall et al, 2014, the Journal of Experimental Medicine).

New Drug Triggers Liver Regeneration After Surgery

Investigators have revealed that an innovative complement inhibitor decreases complement-mediated liver cell death, and actually stimulates postsurgery liver regrowth in mice. Liver cancer often results... Read more

Lab Technologies

view channel

White-Matter Deficits Found in Codeine-Containing Cough Syrup Users

A magnetic resonance imaging (MRI) study of chronic users of codeine-containing cough syrups (CCS) has found deficits in specific regions of brain white matter and linked these changes with increased impulsivity in codeine-containing cough syrup users. These findings were consistent with findings from earlier research of... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.